What is the Bishop score, how is it calculated, and how does it guide decisions about labor induction?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 16, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Bishop Score: Definition, Calculation, and Clinical Application

The Bishop score is a standardized clinical scoring system (0-13 points) that assesses cervical readiness for labor by evaluating five parameters through digital vaginal examination: cervical dilation, effacement, consistency, position, and fetal station. This score remains the standard bedside tool for predicting labor induction success, though it has recognized limitations in predictive accuracy 1.

How the Bishop Score is Calculated

The scoring system assigns points (0-3 for most parameters) across five components:

  • Cervical dilation (0-3 points): closed, 1-2 cm, 3-4 cm, ≥5 cm
  • Cervical effacement (0-3 points): 0-30%, 40-50%, 60-70%, ≥80%
  • Cervical consistency (0-2 points): firm, medium, soft
  • Cervical position (0-2 points): posterior, mid-position, anterior
  • Fetal station (0-3 points): -3, -2, -1/0, +1/+2

Total scores range from 0-13, with higher scores indicating greater cervical favorability.

Simplified Bishop Score Alternative

Recent evidence demonstrates that a simplified three-component score using only dilation, station, and effacement (range 0-9) performs equally well or better than the full five-component score, with similar positive predictive value (87.7% vs 87.0%) and improved correct classification rates (51.0% vs 47.3%) 2. This simplified approach may reduce examination complexity without sacrificing predictive ability.

Clinical Decision-Making Based on Bishop Score

Score Interpretation and Management

Bishop score >6 ("favorable cervix"):

  • Proceed directly with oxytocin induction 3
  • High likelihood of successful vaginal delivery within 24 hours 4
  • Simpler interventions typically sufficient 5

Bishop score 4-6 ("moderately unfavorable"):

  • Consider cervical ripening agents before oxytocin
  • Prostaglandins (dinoprostone, misoprostol) may be used 3
  • Intermediate success rates expected

Bishop score <4 ("unfavorable cervix"):

  • Cervical ripening strongly recommended before induction 5
  • Prostaglandins show superior effectiveness in this group 5
  • Significantly higher risk of cesarean delivery, particularly with scores 0-3 6

Critical Threshold: Bishop Score of 5

A Bishop score >5 represents the optimal cut-off point for clinical decision-making, demonstrating the best statistical performance with 65.5% sensitivity, 95% specificity, and 97.3% positive predictive value for successful induction 4. The 2023 FIGO guidelines specifically recommend using Bishop score >6 versus <6 as a management decision point 7.

Cervical Ripening Options by Bishop Score

For unfavorable cervix (Bishop <6):

  • Prostaglandin E2 (dinoprostone): Vaginal gel or insert with continuous fetal monitoring required from placement until 15 minutes after removal (for inserts) or 30 minutes to 2 hours after gel administration 3
  • Misoprostol: Lower doses (25 µg every 3-6 hours) effective for cervical ripening; higher doses (50 µg every 6 hours) may be appropriate in select situations but carry increased hyperstimulation risk 3
  • Cost consideration: Misoprostol ($0.36-$1.20 per 100 µg tablet) versus dinoprostone gel ($65-$75) or insert (~$165) 3

Important Contraindication

Avoid misoprostol in women with previous cesarean delivery due to uterine rupture risk 3. This is a Level B recommendation based on consistent evidence.

Limitations and Clinical Pitfalls

Predictive Accuracy Issues

The Bishop score has significant limitations that clinicians must recognize:

  • Limited predictive power before 40 weeks: The score fails as a prediction tool for mode of delivery in primiparous women at term before labor onset at gestational ages <40 weeks 8
  • Subjectivity and inter-observer variability: Digital examination introduces measurement inconsistency 9
  • Poor negative predictive value: Only 31.3% for unsuccessful induction 2
  • Population heterogeneity: Performance varies across different patient populations 5

Specific High-Risk Scenarios

Primiparous women with Bishop score 0-3 at ≥41 weeks face:

  • 2.58-fold increased risk of emergency cesarean section (23% vs 11% with scores 4-5) 6
  • Doubled risk of negative childbirth experience (20% vs 10%) 6
  • These findings emphasize the clinical importance of distinguishing very unfavorable (0-3) from moderately unfavorable (4-5) cervical status

Emerging Adjuncts and Future Directions

While the Bishop score remains clinically useful, transvaginal ultrasound parameters show promise as objective adjuncts, particularly:

  • Cervical length: Shorter length associated with shorter induction-to-delivery interval 1
  • Cervical shear wave elastography: Independently predicts successful induction and vaginal delivery (AUC 0.78 vs 0.53 for Bishop score) 9
  • Posterior cervical angle and angle of progression: Additional morphologic parameters 9

However, current evidence shows no difference in labor induction outcomes between patients assessed by transvaginal ultrasound versus Bishop score alone in meta-analysis 1, and routine ultrasound use is not yet supported for induction prediction. Ultrasound may serve best as a complementary tool when combined with clinical assessment 5, 10.

Patient Experience Consideration

Ultrasound assessment provides significantly better patient experience than digital vaginal examination, with nearly 85% of women reporting pain-free examination versus 100% experiencing moderate-to-severe pain with digital examination 9. This may be relevant when repeated cervical assessments are needed.

Practical Clinical Algorithm

  1. Perform Bishop score assessment via digital vaginal examination
  2. If Bishop >6: Proceed with oxytocin induction
  3. If Bishop 4-6: Consider cervical ripening with prostaglandins, then oxytocin
  4. If Bishop 0-3: Strongly recommend cervical ripening before induction; counsel patient about increased cesarean risk (especially primiparous at ≥41 weeks)
  5. Monitor continuously during prostaglandin use per ACOG guidelines 3
  6. Avoid misoprostol in patients with prior cesarean delivery 3

References

Guideline

acr appropriateness criteria® assessment of gravid cervix.

Journal of the American College of Radiology, 2020

Guideline

acog develops guidelines for induction of labor.

American family physician, 2000

Research

[The Bishop score and induction of labor].

Medicinski pregled, 2002

Research

Outcomes of labor induction in primiparous women with unfavorable cervical status at gestational week 41 and beyond. Does the Bishop score matter?

Sexual & reproductive healthcare : official journal of the Swedish Association of Midwives, 2026

Research

FIGO good practice recommendations for induced or spontaneous labor at term: Prep-for-Labor triage to minimize risks and maximize favorable outcomes.

International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics, 2023

Related Questions

What is the difference between Bishop score and Modified Bishop score?
In a 26‑week gestation with an amniotic fluid index of 25 cm, what is the significance and recommended management?
In a patient with a cervix 2 cm dilated, 50 % effaced and fetal head at station –3, what are the indications to start Pitocin (oxytocin) for labor augmentation, and is a Bishop score required?
What is the recommended active management protocol for labor and delivery, including monitoring, induction, analgesia, delivery, and postpartum care?
How should a pregnant patient with prodromal labor be managed?
For a 17-year-old patient with suspected bipolar II currently on seroquel (quetiapine) 25 mg, what is the appropriate next dose and should I switch to the extended-release formulation?
In a patient with bipolar I disorder currently taking lithium 300 mg in the morning and 450 mg at bedtime, lamotrigine (Lamictal) 100 mg at bedtime, and lurasidone (Latuda) 100 mg at bedtime who reports inability to sleep, what medication should be added to treat her insomnia?
What is the recommended preventive and acute management for a 46‑year‑old woman with two migraines per week who has failed prior therapy?
What is the recommended dose of topical minoxidil for an adult male without cardiovascular disease to prevent hair loss?
What preventive treatment is recommended for a 46-year-old woman with chronic migraines occurring twice weekly who has not responded to triptans (e.g., consider galcanezumab [Emgality])?
Should a patient with a bleeding peptic ulcer avoid hot drinks?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.